Literature DB >> 17673680

The NOX on pulmonary hypertension.

Karl A Sanders, John R Hoidal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17673680     DOI： 10.1161/CIRCRESAHA.107.158246

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  17 in total

1.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

2.  Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.

Authors:  Qian Xu; Amol A Kulkarni; Ayyiliath M Sajith; Dilbi Hussein; David Brown; Osman F Güner; M Damoder Reddy; E Blake Watkins; Bernard Lassègue; Kathy K Griendling; J Phillip Bowen
Journal:  Bioorg Med Chem       Date:  2017-12-17       Impact factor: 3.641

3.  NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets.

Authors:  Kathleen E Dennis; J L Aschner; D Milatovic; J W Schmidt; M Aschner; M R Kaplowitz; Y Zhang; Candice D Fike
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-10       Impact factor: 5.464

Review 4.  Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

Review 5.  Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension.

Authors:  Christine Veith; Ralph T Schermuly; Ralf P Brandes; Norbert Weissmann
Journal:  J Physiol       Date:  2015-09-30       Impact factor: 5.182

6.  Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.

Authors:  Eva Nozik-Grayck; Hagir B Suliman; Susan Majka; Joseph Albietz; Zachary Van Rheen; Kevin Roush; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-03       Impact factor: 5.464

7.  Thioredoxin-1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation.

Authors:  Bernadette Chen; Viktoria E Nelin; Morgan L Locy; Yi Jin; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

8.  Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; James C Slaughter; Mark R Kaplowitz; Yongmei Zhang; Judy L Aschner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-29       Impact factor: 5.464

9.  Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

Authors:  Rachel E Nisbet; Jennifer M Bland; Dean J Kleinhenz; Patrick O Mitchell; Erik R Walp; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

10.  NADPH oxidase-mediated endothelial injury in HIV- and opioid-induced pulmonary arterial hypertension.

Authors:  Stuti Agarwal; Himanshu Sharma; Ling Chen; Navneet K Dhillon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-01       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.